Europe Oligonucleotide Synthesis Market: Country-wise Breakdown (2024-2032)

Name: Europe Oligonucleotide Synthesis Market: Country-wise Breakdown (2024-2032)
Creator: Maximize Market Research Pvt. Ltd
Published: 2025-11-20T11:59:43.511Z
License: https://creativecommons.org/licenses/by/4.0/

Free

in USD Million

.js-only{display:none !important;}

Chart preview (first 9 rows), unit: in USD Million.

Europe Oligonucleotide Synthesis Market: Country-wise Breakdown (2024-2032) chart preview

Europe Oligonucleotide Synthesis Market: Country-wise Breakdown (2024-2032) chart data
Year	France	Germany	Italy	Spain	Sweden	Russia
2024	350.34	552.11	219.74	164.39	106.16	121.73
2025	395.13	626.75	246.99	184.08	119.78	136.33
2026	446.43	712.74	278.11	206.5	135.38	152.95
2027	505.68	812.59	313.94	232.25	153.41	172.04
2028	574.85	929.76	355.67	262.14	174.47	194.2
2029	656.69	1069.04	404.92	297.32	199.38	220.29
2030	755.01	1237.1	463.96	339.41	229.32	251.49
2031	875.1	1443.22	535.92	390.59	265.91	289.45
2032	1024.65	1700.87	625.37	454.09	311.48	336.54

Strong R&D Investments to Drive Europe’s Oligonucleotide Synthesis Market Growth

Published by MMR Statistics Reserch Team, November 2025

Strong scientific advances and rising biotech investments have created powerful momentum across leading European economies. The region showcased notable variation in 2024, as the UK valued at USD 468.00 million, France reached USD 350.34 million, and Germany achieved USD 552.11 million, forming a strong base for expansion. In 2025, the Oligonucleotide Synthesis market is estimated to gain further pace, supported by Italy at USD 246.99 million and Spain at USD 184.08 million, driven by growing adoption of genetic engineering and diagnostic applications that continue to influence research priorities.
From 2026 to 2032, the European Oligonucleotide Synthesis Market is projected to scale substantially as automation, high-precision platforms, and genomic innovation strengthen country-level demand. Sweden is anticipated to grow from USD 135.38 million in 2026 to USD 311.48 million in 2032, highlighting increasing R&D intensity, while Russia is expected to rise from USD 152.95 million to USD 336.54 million over the same period. With the Rest of Europe also expanding steadily, the region presents strategic opportunities for stakeholders seeking to capitalize on evolving therapeutic and molecular research trends.

More statistics on Genetic Synthesis

Download

Information

Unit

in USD Million

Region

Europe

Time Period

2024-2032

Source Name

Maximize Market Research Pvt. Ltd

Source Link

http://www.maximizemarketresearch.com

Publisher Name

Maximize Market Research Pvt. Ltd

Publisher Link

http://www.maximizemarketresearch.com

Stay ahead of Genetic Synthesis with tailored access

Sample free-tier statistics or unlock premium coverage for this topic with team-friendly usage rights.

Discover

Try free-tier statistics before committing to a plan.

Start for Free

Professional

Unlock premium coverage across this topic with analyst support.

Select Plan

Contact our team

Need a bespoke deep-dive on Genetic Synthesis?

Tell us about your KPIs and coverage priorities. We can tailor a briefing, share methodology notes, or build a custom dataset that complements the reports and statistics you are browsing.

Talk with an analyst

Europe Oligonucleotide Synthesis Market: Country-wise Breakdown (2024-2032)

in USD Million

Strong R&D Investments to Drive Europe’s Oligonucleotide Synthesis Market Growth

OTHER STATISTICS ON TOPIC

More statistics on Genetic Synthesis

Strong R&D Investments to Drive Europe’s Oligonucleotide Synthesis Market Growth

OTHER STATISTICS ON TOPIC

More statistics on Genetic Synthesis

Download

Related Topics

Download

Related Topics

Market Research Reports on Genetic Synthesis

Stay ahead of Genetic Synthesis with tailored access

Need a bespoke deep-dive on Genetic Synthesis?